Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: A randomized controlled trial

Obstetrics and Gynecology

Volumn 119, Issue 5, 2012, Pages 989-999

  Westhoff, Carolyn ^a,b,c,d,e   Kaunitz, Andrew M ^a,b,c,d,e   Korver, Tjeerd ^a,b,c,d,e   Sommer, Werner ^a,b,c,d,e   Bahamondes, Luis ^a,b,c,d,e   Darney, Philip ^a,b,c,d,e   Verhoeven, Carole ^a,b,c,d,e  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c NV ORGANON   (Netherlands)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTRADIOL PLUS NOMEGESTROL ACETATE;

ACNE; ADULT; ARTICLE; BODY MASS; BREAKTHROUGH BLEEDING; CHOLECYSTITIS; CHOLELITHIASIS; COMPARATIVE STUDY; CONTRACEPTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; METRORRHAGIA; MIGRAINE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NORMAL HUMAN; OPEN STUDY; OPTIC NEURITIS; PEARL INDEX; PHASE 3 CLINICAL TRIAL; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; WEIGHT GAIN; WITHDRAWAL BLEEDING;

ADOLESCENT; ADULT; ANDROSTENES; CONTRACEPTIVES, ORAL, COMBINED; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; ETHINYL ESTRADIOL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MEGESTROL; MIDDLE AGED; NORPREGNADIENES; PREGNANCY; PROPORTIONAL HAZARDS MODELS; YOUNG ADULT;

EID: 84860154371     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318250c3a0     Document Type: Article

References (29)

1. United Nations Department of Economic and Social Affairs Population Division. World contraceptive use 2011. Available at: www.un.org/esa/population/ publications/contraceptive2011/wallchart-front.pdf. Retrieved October 18, 2011.
2. Astedt B, Jeppsson S, Liedholm P, Rannevik G, Svanberg L. Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17beta-oestradiol. Br J Obstet Gynaecol 1979;86:732-6. (Pubitemid 9245029)
3. Serup J, Bostofte E, Larsen S, Westergaard J, Lebech PE. Natural oestrogens for oral contraception. Lancet 1979;2: 471-2. (Pubitemid 9250419)
4. Duijkers IJM, Klipping C, Grob P, Korver T. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur J Contracept Reprod Health Care 2010;15:314-25.
5. Gaussem P, Alhenc-Gelas M, Thomas JL, Bachelot-Loza C, Remones V, Dali Ali F, et al. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17 β-estradiol, compared with those of levonorgestrel/ethinyl estradiol: a double-blind, randomised study. Thromb Haemost 2011;105: 560-7.
6. Mansour D, Verhoeven C, Sommer W, Weisberg E, Taneepanichskul S, Melis GB, et al. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen. Eur J Contracept Reprod Health Care 2011;16:430-43.
7. Lello S. Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy. Drugs 2010;70:541-59.
8. van Diepen HA, Lam TW, Kuil CW. Nomegestrol acetate: steroid receptor transactivation profile in Chinese hamster ovary cells and ovulation inhibition in rat and monkey. Contraception 2011;84:199-204.
9. Ågren UM, Anttila M, Mäenpää-Liukko K, Rantala ML, Rautiainen H, Sommer W, et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. Eur J Contracept Reprod Health Care 2011;16:458-67.
10. Ågren UM, Anttila M, Mäenpää-Liukko K, Rantala ML, Rautiainen H, Sommer W, et al. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. Eur J Contracept Reprod Health Care 2011;16:444-57.
11. World Health Organization; Reproductive Health and Research. Medical eligibility criteria for contraceptive use. 3rd ed. Geneva (Switzerland): World Health Organization; 2004.
12. Benda N, Gerlinger C, van der Meulen EA, Endrikat J. Sample size calculation for clinical studies on the efficacy of a new contraceptive method. Biom J 2004;46:141-50. (Pubitemid 41448950)
13. European Medicines Agency; Committee for Medicinal Products for Human Use. Guideline on clinical investigation of steroid contraceptives in women. London (UK): European Medicines Agency; 2005.
14. Gerlinger C, Endrikat J, van der Meulen EA, Dieben TOM, Dü sterberg B. Recommendation for confidence interval and sample size calculation for the Pearl Index. Eur J Contracept Reprod Health Care 2003;8:87-92. (Pubitemid 36791750)
15. Belsey EM, Farley TM. The analysis of menstrual bleeding patterns: a review. Contraception 1988;38:129-56.
16. Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1986;34:253-60. (Pubitemid 17177017)
17. Der G, Everitt, BS. Statistical analysis of medical data using SAS. Boca Raton (FL): Chapman & Hall/CRC, Taylor & Francis Group, LLC; 2006.
18. Dinger J, Minh TD, Buttmann N, Bardenheuer K. Effectiveness of oral contraceptive pills in a large US cohort comparing progestogen and regimen. Obstet Gynecol 2011;117:33-40.
19. Stanczyk FZ. Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception. Rev Endocr Metab Disord 2002;3:211-24.
20. Read CM. New regimens with combined oral contraceptive pills-moving away from traditional 21/7 cycles. Eur J Contracept Reprod Health Care 2010;15:S32-41.
21. Fruzzetti F, Lazzarini V, Ricci C, Quirici B, Gambacciani M, Paoletti AM, et al. Effect of an oral contraceptive containing 30μg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention. Contraception 2007;76:190-4. (Pubitemid 47247660)
22. Guang-Sheng F, Mei-Lu B, Li-Nan C, Xiao-Ming C, Zi-Rong H, Zi-Yan H, et al. Efficacy and safety of the combined oral contraceptive ethinylestradiol/ drospirenone (Yasmin®) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial. Clin Drug Investig 2010;30:387-96.
23. Gallo MF, Lopez LM, Grimes DA, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. The Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD003987. DOI: 10.1002/14651858.CD003987.pub4.
24. Lindh I, Ellström AA, Milsom I. The long-term influence of combined oral contraceptives on body weight. Hum Reprod 2011;26:1917-24.
25. Coney P, Washenik K, Langley RG, DiGiovanna JJ, Harrison DD. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception 2001;63:297-302. (Pubitemid 32970785)
26. Thiboutot D, Archer DF, Lemay A, Washenik K, Roberts J, Harrison DD. A randomized, controlled trial of a low-dose contraceptive containing 20μg of ethinyl estradiol and 100μg of levonorgestrel for acne treatment. Fertil Steril 2001;76: 461-8.
27. Hassan DF, Petta CA, Aldrighi JM, Bahamondes L, Perrotti M. Weight variation in a cohort of women using copper IUD for contraception. Contraception 2003;68:27-30. (Pubitemid 37271987)
28. Westhoff CL, Heartwell S, Edwards S, Zieman M, Stuart G, Cwiak C, et al. Oral contraceptive discontinuation: do side effects matter? Am J Obstet Gynecol 2007;196:412.e1-6; discussion 412.e6-7.
29. Dieben TO, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 2002;100:585-93. (Pubitemid 35246150)